Ministry of Health (MHLW) orders temporary stop of cord blood therapy in 11 clinics

11 medical institutions, mainly in Tokyo, were ordered to stop cord-blood therapy of cancer or aging because they had not requested permission from the designated MHLW committee. The cord blood was obtained from undisclosed cell-processing facilities and no provision plans were submitted.

Nikkei Biotech news release, June 29, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny